1.
De Marco G, Gerloni V, Pontikaki I, Lurati A, Teruzzi B, Salmaso A, et al. Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy. Reumatismo [Internet]. 2007 Mar. 30 [cited 2024 Dec. 11];59(1):50-6. Available from: https://www.reumatismo.org/reuma/article/view/reumatismo.2007.50